1. Advisorkhoj
  2. News
  3. Mutual Fund
  4. HDFC Mutual Fund launches HDFC Charity Fund for Cancer Cure

HDFC Mutual Fund launches HDFC Charity Fund for Cancer Cure

Mutual Fund

by Advisorkhoj Team | Mutual Fund | 15 Downloaded

NFO period: 10th March – 24th March, 2017

Highlights of the NFO:

  • Scheme type – A close-ended scheme

  • Investment objective –

    • Arbitrage Plan

      – To generate income through arbitrage opportunities between cash and derivative market and through investments in debt and money market instruments.

    • Debt Plan

      – To generate income through investments in Debt / Money Market Instruments and Government Securities maturing on or before the maturity date of the Plan.

    • However, there can be no assurance that the investment objective of the Scheme / Plan(s) will be realized.

  • Product suitability – The product is suitable for investors who are seeking

    • Arbitrage Plan

      – To generate regular income over the tenure of the scheme (1136 days) income through arbitrage opportunities between cash and derivative market and through investments in debt and money market instruments.

    • Debt Plan

      – To generate regular income over the tenure of the Scheme (1136 days) by investing in Debt/Money Market Instruments and Government Securities.

  • Minimum Application Amount – First investment is Rs. 50,000/- and in multiples of Rs. 1,000/- thereafter

  • Plan/ Options available – Arbitrage Plan and Debt Plan. Both the Plans offer Regular Option and Direct Option.

  • Fund Manager – Mr. Krishan Kumar Daga, Mr. Anil Bamboli and Mr. Rakesh Vyas

  • Benchmark –

    • Arbitrage Plan – NIFTY 50 Arbitrage Index

    • Debt Plan – Crisil Short Term Bond Fund Index

  • Maturity – 1136 days from the date of allotment

(Mutual Fund investments are subject to market risks, read all scheme related documents carefully.)

Locate HDFC Mutual Fund Advisors in your city
comments powered by Disqus

© 2016 Advisorkhoj - A Gamechanger Business Services (I) Pvt. Ltd. Brand - All Rights Reserved

Feedback